CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
About CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $6.0K
- Net income
- -$6.0M
- Total assets
- $7.8M
- Market cap
- $7.6M
- Gross margin
- 63.4%
- Operating margin
- -102380.2%
- Net margin
- -99916.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $6.0K
- Cost of revenue
- $2.2K
- Gross profit
- $3.8K
- Operating expenses
- $6.1M
- Operating income
- -$6.1M
- Income tax
- $0
- Net income
- -$6.0M
- EPS (diluted)
- $-2.52
Balance sheet
- Total assets
- $7.8M
- Current assets
- $7.4M
- Total liabilities
- $284.9K
- Current liabilities
- $284.9K
- Shareholders’ equity
- $7.5M
Cash flow
- Operating cash flow
- -$5.9M
- Investing cash flow
- -$50.5K
- Financing cash flow
- $7.2M
- Net cash flow
- $1.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $7.6M
- EPS (diluted)
- $-2.52
- Shares outstanding
- 9.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 30, 2009
Creative Medical Technology Holdings, Inc. (CELZ) Stock Price
- Reported a net loss of $6.0M in FY2025.
- Revenue declined 93% from FY2021 to FY2025.
- Gross margin of 63.4%, net margin -99916.8%.
- Trading 86% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC..
Write a review
News about CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
News & sentiment via Polygon.io
Creative Medical Technology Holdings, Inc.: frequently asked questions
Is Creative Medical Technology Holdings, Inc. an American company?
Creative Medical Technology Holdings, Inc. is a US-based company headquartered in Phoenix, Arizona, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Creative Medical Technology Holdings, Inc. headquartered?
Creative Medical Technology Holdings, Inc. is headquartered in Phoenix, Arizona, United States.
Is Creative Medical Technology Holdings, Inc. publicly traded?
Yes — Creative Medical Technology Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol CELZ on the NASDAQ.
What does Creative Medical Technology Holdings, Inc. do?
Creative Medical Technology Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
